Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  recombinant Saccharomyces cerevisia-CEA(610D) vaccine GI-6207
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GI-6207-02, NCI-2015-01927, GI-6207, NCI-2013-01587, NCT01856920
Start Over